Benevolent
Curated by SignalAI-powered platform for drug discovery and development
Overview
AI-powered platform for drug discovery and development. The company aims to discover and develop an AI-enabled drug discovery platform for pharmaceutical solutions. The company's technology platform includes JACS Judgement Augmented Correlation System that learning-based AI which is used to produce medical data for the discovery and development of drugs. The company has developed integrated and complementary subsidiaries ‘BenevolentBio’ that focuses on the application of its technology platform in human health and veterinary medicine.
Key facts
- Founded
- 2013
- Headquarters
- London, United Kingdom
- Stage
- Sign up to view
- Industry
- Health Technology
Contact
- Primary office
- Sign up to view
- Sign up to view
- Phone
- Sign up to view